Keros TherapeuticsKROS
13F holders, Q3 2024 (September 30)164holders +12
25new positions
15sold out
5famous investors
$58.09avg. 13F price*
At the end of Q3 2024, 164 institutions reported holding Keros Therapeutics Inc. (KROS) in their 13F filings, up 12 from Q2 2024. 25 opened new positions and 15 sold out. The largest holders were FMR LLC ($284.5M), BlackRock, Inc. ($152.9M) and Alkeon Capital Management LLC ($110.2M). 5 famous investors held it, including Steve Cohen (0.2% of Point72 Asset Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Keros Therapeutics Inc.
- CUSIP
- 492327101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 25 | $95.3M |
| Exits | 15 | $18.4M |
All 13F filers, Q2 2024 → Q3 2024: 5,534,227 shares bought and 2,211,863 shares sold, net +3,322,364 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 164 holders
| FMR LLC | 0.02% | Add +3.8% | 4,899,134 | $284.5M |
| BlackRock, Inc. | 0.00% | — | 2,632,608 | $152.9M |
| Alkeon Capital Management LLC | 0.60% | Add +18.7% | 1,897,601 | $110.2M |
| Vanguard Group Inc. | 0.00% | Add +5.7% | 1,856,418 | $107.8M |
| Darwin Global Management, Ltd. | 7.20% | Reduce -0.1% | 1,523,732 | $88.5M |
| T. Rowe Price Associates Inc. | 0.01% | Add +27.5% | 1,514,505 | $87.9M |
| State Street Corp. | 0.00% | Reduce -8.8% | 1,113,590 | $64.7M |
| Orbimed Advisors LLC | 1.08% | Reduce -19.7% | 1,018,734 | $59.2M |
| Point72 Asset Management | 0.20% | Add +155.9% | 947,570 | $55.0M |
| TCG Crossover Management, LLC | 4.33% | No change | 879,344 | $51.1M |
| Jefferies Financial Group Inc. | 0.88% | Reduce -3.6% | 866,737 | $50.3M |
| Holocene Advisors, LP | 0.20% | Add +22.5% | 843,110 | $49.0M |
| Woodline Partners LP | 0.37% | Reduce -1.6% | 763,548 | $44.3M |
| Geode Capital Management, LLC | 0.00% | Add +6.8% | 725,621 | $42.1M |
| Braidwell LP | 1.77% | Reduce -28.0% | 707,240 | $41.1M |
| Citadel Advisors | 0.04% | Add +71.7% | 704,923 | $40.9M |
| Millennium Management | 0.03% | Add +45.8% | 572,990 | $33.3M |
| Redmile Group, LLC | 1.89% | No change | 552,506 | $32.1M |
| Paradigm Biocapital Advisors LP | 1.07% | New | 525,037 | $30.5M |
| ADAR1 Capital Management, LLC | 4.33% | Reduce -18.9% | 445,068 | $25.8M |
| Parkman Healthcare Partners LLC | 3.13% | Add +112.3% | 421,782 | $24.5M |
| Opaleye Management Inc. | 3.88% | Add +7.6% | 395,276 | $23.0M |
| Nantahala Capital Management, LLC | 1.87% | Add +0.8% | 381,659 | $22.2M |
| Eventide Asset Management, LLC | 0.38% | Reduce -23.9% | 380,000 | $22.1M |
| Morgan Stanley | 0.00% | Add +8.8% | 365,297 | $21.2M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -31.8% | 355,664 | $20.7M |
| Candriam S.C.A. | 0.12% | Reduce -21.8% | 345,384 | $20.1M |
| Balyasny Asset Management L.P. | 0.05% | Add +267.2% | 325,434 | $18.9M |
| Franklin Resources Inc. | 0.00% | Reduce -28.0% | 288,234 | $17.4M |
| American Century Companies Inc. | 0.01% | Reduce -0.2% | 297,669 | $17.3M |
| Avidity Partners Management LP | 0.87% | Reduce -14.6% | 293,200 | $17.0M |
| Frontier Capital Management Co. LLC | 0.16% | New | 287,484 | $16.7M |
| Mangrove Partners Im, LLC | 1.63% | New | 286,995 | $16.7M |
| Northern Trust Corp. | 0.00% | Add +12.6% | 266,356 | $15.5M |
| Nuveen Asset Management, LLC | 0.00% | Add +142.5% | 261,348 | $15.2M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +14.3% | 260,120 | $15.1M |
| Soleus Capital Management, L.P. | 1.08% | Add +1.4% | 224,600 | $13.0M |
| Assenagon Asset Management S.A. | 0.03% | Add +814.6% | 223,704 | $13.0M |
| Integral Health Asset Management, LLC | 1.37% | Add +135.3% | 200,000 | $11.6M |
| Schonfeld Strategic Advisors LLC | 0.09% | Add +484.4% | 199,354 | $11.6M |
| EcoR1 Capital, LLC | 0.37% | No change | 187,500 | $10.9M |
| D. E. Shaw & Co. | 0.02% | Add +6.0% | 186,288 | $10.8M |
| Voya Investment Management LLC | 0.01% | Add +212.5% | 175,294 | $10.2M |
| Bank of America Corp. | 0.00% | Reduce -4.4% | 171,071 | $9.9M |
| Granahan Investment Management, LLC | 0.37% | Add +11.1% | 161,130 | $9.4M |
| Alliancebernstein L.P. | 0.00% | Add +5.2% | 158,205 | $9.2M |
| Emerald Advisers, LLC | 0.35% | New | 155,545 | $9.0M |
| Dimensional Fund Advisors LP | 0.00% | Reduce -5.7% | 152,436 | $8.9M |
| Blue Owl Capital Holdings LP | 1.38% | Reduce -22.2% | 122,633 | $7.1M |
| Emerald Mutual Fund Advisers Trust | 0.34% | New | 112,613 | $6.5M |
| WCM Investment Management, LLC | 0.01% | Reduce -2.3% | 113,860 | $6.4M |
| Russell Investments Group, Ltd. | 0.01% | Add +24.2% | 102,316 | $5.9M |
| PFM Health Sciences, LP | 0.34% | Add +202.9% | 101,050 | $5.9M |
| Bank of New York Mellon Corp | 0.00% | Reduce -19.4% | 95,416 | $5.5M |
| Janus Henderson Group PLC | 0.00% | Add +543.8% | 92,110 | $5.4M |
| Stempoint Capital LP | 1.51% | New | 86,930 | $5.0M |
| DAFNA Capital Management LLC | 1.02% | Add +8.9% | 73,754 | $4.3M |
| Ensign Peak Advisors, Inc | 0.01% | No change | 71,740 | $4.2M |
| Altium Capital Management LLC | 1.20% | New | 69,000 | $4.0M |
| Jane Street Group, LLC | 0.01% | Add +34.0% | 60,178 | $3.5M |
| Barclays PLC | 0.00% | Add +140.1% | 60,014 | $3.5M |
| Fred Alger Management, LLC | 0.02% | Add +20.7% | 59,138 | $3.4M |
| Swiss National Bank | 0.00% | Reduce -0.9% | 56,300 | $3.3M |
| UBS Group AG | 0.00% | Reduce -14.7% | 55,907 | $3.2M |
| J. Goldman & Co LP | 0.14% | Add +80.2% | 54,236 | $3.1M |
| HighVista Strategies LLC | 1.04% | Add +32.9% | 52,107 | $3.0M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +4.7% | 50,552 | $2.9M |
| Marshall Wace, LLP | 0.00% | Add +94.4% | 43,500 | $2.5M |
| Rafferty Asset Management, LLC | 0.01% | Reduce -28.6% | 41,112 | $2.4M |
| Rhumbline Advisers | 0.00% | Reduce -2.8% | 40,476 | $2.4M |
| Engineers Gate Manager LP | 0.04% | Reduce -17.0% | 39,669 | $2.3M |
| JPMorgan Chase & Co. | 0.00% | Add +1.4% | 31,117 | $1.8M |
| Legal & General Group Plc | 0.00% | No change | 29,115 | $1.7M |
| Qube Research & Technologies Ltd | 0.00% | Reduce -10.6% | 27,941 | $1.6M |
| Alps Advisors Inc. | 0.01% | Reduce -0.8% | 27,905 | $1.6M |
| NEOS Investment Management LLC | 0.05% | Add +26.8% | 27,778 | $1.6M |
| State of Wisconsin Investment Board | 0.00% | Reduce -12.7% | 27,720 | $1.6M |
| California State Teachers Retirement System | 0.00% | Reduce -3.2% | 27,354 | $1.6M |
| BIT Capital GmbH | 0.15% | Add +15.4% | 26,237 | $1.5M |
| Comerica Bank | 0.01% | New | 25,791 | $1.5M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.04% | Add +10.2% | 24,752 | $1.4M |
| First Trust Advisors LP | 0.00% | Add +138.3% | 24,130 | $1.4M |
| Citigroup Inc. | 0.00% | Add +85.8% | 23,381 | $1.4M |
| Platinum Investment Management Ltd. | 0.05% | No change | 20,293 | $1.2M |
| Erste Asset Management GmbH | 0.01% | No change | 20,700 | $1.2M |
| Artia Global Partners LP | 0.33% | No change | 20,000 | $1.2M |
| Tudor Investment Corporation | 0.01% | Add +91.0% | 19,787 | $1.1M |
| Point72 (DIFC) Ltd | 0.09% | Add +9.8% | 19,255 | $1.1M |
| Deutsche Bank AG | 0.00% | Reduce -85.1% | 18,510 | $1.1M |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +17.2% | 17,798 | $1.0M |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 17,674 | $1.0M |
| MetLife Investment Management, LLC | 0.01% | No change | 17,071 | $991K |
| Manufacturers Life Insurance Company, The | 0.00% | Reduce -0.2% | 16,806 | $976K |
| B. Metzler seel. Sohn & Co. Holding AG | 0.01% | — | 16,103 | $935K |
| B. Metzler seel. Sohn & Co. AG | 0.01% | No change | 16,103 | $935K |
| Corebridge Financial, Inc. | 0.00% | Reduce -0.6% | 15,755 | $915K |
| Jump Financial, LLC | 0.02% | Add +13.3% | 15,503 | $900K |
| Twinbeech Capital LP | 0.02% | Reduce -68.6% | 15,378 | $893K |
| Wellington Management Group LLP | 0.00% | New | 14,949 | $868K |
| Nebula Research & Development LLC | 0.09% | Add +62.8% | 13,439 | $780K |
"% of holder's portfolio" is KROS's weight in each manager's 13F, not the share of Keros Therapeutics Inc. the manager owns.